| 臺大學術典藏 |
2021-02-02T02:47:58Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; Liou J.-M.; Wu M.-S.; PING-NING HSU; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-02T02:47:58Z |
Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis
|
Tsai H.-F.; Wu C.-S.; Chen Y.-L.; Liao H.-J.; Chyuan I.-T.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:58Z |
Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study
|
Yu K.-H.; Lai J.-H.; PING-NING HSU; Chen D.-Y.; Chen C.-J.; Lin H.-Y. |
| 臺大學術典藏 |
2021-02-02T02:47:57Z |
Cumulative burden of glucocorticoid-related adverse events in patients with systemic lupus erythematosus: Findings from a 12-year longitudinal study
|
Chen H.-L.; Shen L.-J.; PING-NING HSU; Shen C.-Y.; Hall S.A.; Hsiao F.-Y. |
| 臺大學術典藏 |
2021-02-02T02:47:57Z |
Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: A review of the literature
|
Chen D.-Y.; Lau C.S.; Elzorkany B.; PING-NING HSU; Praprotnik S.; Vasilescu R.; Marshall L.; Llamado L. |
| 臺大學術典藏 |
2021-02-02T02:47:57Z |
Cancer immunotherapy by targeting immune checkpoints: Mechanism of T cell dysfunction in cancer immunity and new therapeutic targets John T Kung
|
Tsai H.-F.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:57Z |
Modulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis by Helicobacter pylori in immune pathogenesis of gastric mucosal damage
|
Tsai H.-F.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:56Z |
Tumor necrosis factor: The key to hepatitis B viral clearance
|
Chyuan I.-T.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:56Z |
TRAIL-mediated suppression of T cell receptor signaling inhibits T cell activation and inflammation in experimental autoimmune encephalomyelitis
|
Chyuan I.-T.; Tsai H.-F.; Wu C.-S.; Sung C.-C.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:56Z |
An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis
|
Chyuan I.-T.; Tsai H.-F.; Liao H.-J.; Wu C.-S.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:56Z |
C-FLIP is a target of the E3 ligase deltex1 in gastric cancer article /13/2 /82/80 /14/19 /96/31 /38/35
|
Hsu T.-S.; Mo S.-T.; PING-NING HSU; Lai M.-Z. |
| 臺大學術典藏 |
2021-02-02T02:47:55Z |
TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment
|
Liao H.-J.; Tsai H.-F.; Wu C.-S.; Chyuan I.-T.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:55Z |
Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy
|
Yang N.-Y.; Wang C.-Y.; Chyuan I.-T.; Wu K.-J.; Tu Y.-K.; Chang C.-W.; PING-NING HSU; Kuo M.Y.-P.; Chen Y.-W. |
| 臺大學術典藏 |
2021-02-02T02:47:55Z |
Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma
|
Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; PING-NING HSU; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2021-02-02T02:47:54Z |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; PING-NING HSU; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway
|
Chyuan I.T.; Tsai H.F.; Wu C.S.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study
|
van der Heijde D.; Strand V.; Tanaka Y.; Keystone E.; Kremer J.; Zerbini C.A.F.; Cardiel M.H.; Cohen S.; Nash P.; Song Y.-W.; Tegzová D.; Gruben D.; Wallenstein G.; Connell C.A.; Fleischmann R.; Hall S.; Nicholls D.; Rischmueller M.; Baker M.F.; Bessette L.; Cividino A.A.; Haraoui B.; Niall Jones H.; Keystone E.C.; Khraishi M.; Thorne J.; Birbara C.A.; Baraf H.S.B.; Bathon J.M.; Brodsky A.L.; Cush J.J.; Dikranian A.H.; Diri E.; Dura P.A.; Lohr K.M.; Fleischmann R.M.; Griffin R.M.; Halter D.G.; Hargrove J.K.; Bouda D.W.; Reddy Pasya S.K.; Hill G.L.; Jackson R.E.; Kafka S.P.; Kaine J.L.; Katzenstein P.L.; Kempf K.J.; Kolba K.S.; Kremer J.M.; Longley S.; Mathews S.D.; Milton A.C.; Misischia R.J.; Moorman H.A.; Moreland L.W.; Niemer M.W.; Palmer W.R.; Sayers M.E.; Schuette P.T.; Shamim T.; Shergy W.J.; Sikes D.H.; Silverfield J.C.; Siva C.; Taborn J.D.; Walsh B.T.; Wells A.F.; Wolfe S.M.; Adhikari P.; Amano K.; Bae S.-C.; Chandrashekara S.; Chopra A.K.; PING-NING HSU; Iwahashi M.; Kadel J.K.; Kawabe Y.; Koh E.-M.; Lan J.-L.; Lee S.-K.; Lin H.-Y.; Liou L.-B.; Liu M.-F.; Migita K.; Miyamoto T.; Miyasaka N.; Mori S.; Munakata Y.; Ohta S.; Park W.; Park S.-H.; Rao U.R.; Shim S.C.; Shobha V.; Takasaki Y.; Takeuchi T.; Tanaka Y.; Tohma S.; Tsai W.-C.; Ueki Y.; Veeravalli S.C.M.; Wagh S.; Yamanaka H.; Yoo B.; Batalov A.; Bichoversuska D.; Dvorak Z.; Goranov I.; Hrytsenko H.M.; Kopackova J.; Mosterova Z.; Oparanov B.; Petrov A.; Pokrzywnicka-Gajek I.; Povoroznyuk V.V.; Rosa J.; Ruzga Z.; Settas L.; Stanislavchuk M.A.; Tseluyko V.I.; Vitek P.; de Freitas Zerbini C.A.; Brenol J.C.T.; Cardiel-Rios M.H.; Escalante W.J.O.; Maldonado-Lopez M.C.; Jaller Raad J.J.; Hernandez J.D.M.; Jauregui E.A.; Keiserman M.W.; Melazzi A.C.C.; Pascual-Ramos V.; Pinto L.T.; Radominski S.C.; Ximenes A.C.; de Morales S.V.; the ORAL Scan Investigators |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan
|
Chen D.-Y.; PING-NING HSU; Tang C.-H.; Claxton L.; Valluri S.; Gerber R.A. |
| 臺大學術典藏 |
2021-02-02T02:47:52Z |
Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection
|
Wu C.-S.; Chyuan I.-T.; Chiu Y.-L.; Chen W.-L.; Shen C.-Y.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:52Z |
Efficacy and safety of opinercept tumor necrosis factor inhibitor therapy for drug-refractory rheumatoid arthritis: A randomized clinical trial
|
Liang T.-H.; Lee C.-S.; Lee S.-S.; Wu C.-S.; Chen K.-H.; PING-NING HSU; Lin H.-Y. |
| 臺大學術典藏 |
2021-02-02T02:47:52Z |
TRAIL regulates T cell activation and suppresses inflammation in autoimmune diseases
|
Chyuan I.-T.; PING-NING HSU |
| 臺大學術典藏 |
2021-02-02T02:47:52Z |
Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus
|
Sung C.-C.; Horng J.-H.; Siao S.-H.; Chyuan I.-T.; Tsai H.-F.; Chen P.-J.; PING-NING HSU |
| 臺大學術典藏 |
2020-08-14T01:06:30Z |
Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus
|
PING-NING HSU; Chen, Pei-Jer; Tsai, Hwei-Fang; Chyuan, I-Tsu; Horng, Jau-Hau; Siao, Shih-Hong; Sung, Chi-Chang |
| 臺大學術典藏 |
2020-08-14T00:45:41Z |
TRAIL regulates T cell activation and suppresses inflammation in autoimmune diseases
|
Chyuan, I-Tsu; PING-NING HSU |
| 臺大學術典藏 |
2020 |
Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial
|
HSIN-YI LIN; Liang, TH; Lee, CS; SS LEE; Wu, CS; Chen, KH; PING-NING HSU |
